Stage IV Uterine Corpus Leiomyosarcoma AJCC v8
4 clinical trials · Condition
◉ Watch Stage IV Uterine Corpus Leiomyosarcoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma (NCT04200443) | City of Hope Medical Center | 2020-01-14 |
| A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma (NCT03880019) | National Cancer Institute (NCI) | 2019-08-19 |
| Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma (NCT02601209) | National Cancer Institute (NCI) | 2015-11-30 |
Track Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.